UBS AM’s Accenture ACN Stock Holding History

UBS AM’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15B	Buy	5,821,349 +427,531	+8%	+$99.6M	0.24%	83
2025 Q4	$1.45B	Buy	5,393,818 +63,760	+1%	+$16.2M	0.31%	57
2025 Q3	$1.31B	Sell	5,330,058 -1,608,813	-23%	-$419M	0.29%	65
2025 Q2	$2.07B	Buy	6,938,871 +775,478	+13%	+$236M	0.42%	38
2025 Q1	$1.92B	Buy	6,163,393 +126,548	+2%	+$44.7M	0.49%	31
2024 Q4	$2.12B	Buy	6,036,845 +545,109	+10%	+$196M	0.5%	31
2024 Q3	$1.94B	Buy	5,491,736 +4,345,039	+379%	+$1.43B	0.5%	30
2024 Q2	$348M	Sell	1,146,697 -2,463,247	-68%	-$755M	0.1%	179
2024 Q1	$1.25B	Buy	3,609,944 +167,573	+5%	+$61.1M	0.44%	37
2023 Q4	$1.21B	Buy	3,442,371 +74,843	+2%	+$24.1M	0.48%	32
2023 Q3	$1.03B	Sell	3,367,528 -206,753	-6%	-$65.1M	0.46%	35
2023 Q2	$1.02B	Hold	3,574,281	–	–	0.49%	32
2023 Q1	$1.02B	Buy	3,574,281 +28,299	+0.8%	+$7.71M	0.49%	32
2022 Q4	$946M	Sell	3,545,982 -1,911,423	-35%	-$529M	0.5%	33
2022 Q3	$1.4B	Buy	5,457,405 +1,603,071	+42%	+$463M	0.79%	13
2022 Q2	$1.07B	Sell	3,854,334 -159,534	-4%	-$47.9M	0.56%	27
2022 Q1	$1.35B	Sell	4,013,868 -449,719	-10%	-$152M	0.58%	23
2021 Q4	$1.85B	Buy	4,463,587 +1,235,797	+38%	+$450M	0.71%	16
2021 Q3	$1.03B	Sell	3,227,790 -42,439	-1%	-$13.8M	0.43%	40
2021 Q2	$964M	Sell	3,270,229 -908,252	-22%	-$260M	0.41%	40
2021 Q1	$1.15B	Buy	4,178,481 +7,952	+0.2%	+$2.06M	0.51%	26
2020 Q4	$1.09B	Sell	4,170,529 -645,967	-13%	-$155M	0.51%	30
2020 Q3	$1.09B	Sell	4,816,496 -25,500	-0.5%	-$5.84M	0.58%	24
2020 Q2	$1.04B	Buy	4,841,996 +134,889	+3%	+$25.5M	0.64%	22
2020 Q1	$768M	Buy	4,707,107 +90,380	+2%	+$17.4M	0.55%	32
2019 Q4	$972M	Buy	4,616,727 +1,181,132	+34%	+$230M	0.6%	26
2019 Q3	$661M	Sell	3,435,595 -63,498	-2%	-$12.3M	0.45%	43
2019 Q2	$647M	Buy	3,499,093 +307,085	+10%	+$55.2M	0.46%	37
2019 Q1	$562M	Sell	3,192,008 -112,744	-3%	-$17.7M	0.42%	45
2018 Q4	$466M	Buy	3,304,752 +107,946	+3%	+$17.1M	0.4%	50
2018 Q3	$544M	Buy	3,196,806 +172,463	+6%	+$28.7M	0.4%	45
2018 Q2	$495M	Buy	3,024,343 +166,579	+6%	+$25.9M	0.38%	49
2018 Q1	$439M	Buy	2,857,764 +98,187	+4%	+$15.6M	0.35%	56
2017 Q4	$422M	Buy	2,759,577 +3,952	+0.1%	+$573K	0.36%	61
2017 Q3	$372M	Buy	2,755,625 +66,912	+2%	+$8.72M	0.34%	61
2017 Q2	$333M	Buy	2,688,713 +22,465	+0.8%	+$2.74M	0.32%	64
2017 Q1	$320M	Sell	2,666,248 -979,100	-27%	-$117M	0.33%	61
2016 Q4	$427M	Buy	3,645,348 +25,957	+0.7%	+$3.08M	0.48%	40
2016 Q3	$442M	Sell	3,619,391 -211,816	-6%	-$24.1M	0.48%	45
2016 Q2	$434M	Buy	3,831,207 +261,092	+7%	+$30.3M	0.49%	42
2016 Q1	$412M	Buy	3,570,115 +329,656	+10%	+$33.9M	0.48%	41
2015 Q4	$339M	Sell	3,240,459 -328,346	-9%	-$34.7M	0.39%	54
2015 Q3	$351M	Sell	3,568,805 -141,866	-4%	-$14.1M	0.39%	54
2015 Q2	$359M	Buy	3,710,671 +667,141	+22%	+$63.8M	0.34%	64
2015 Q1	$285M	Sell	3,043,530 -45,162	-1%	-$4.03M	0.27%	81
2014 Q4	$276M	Sell	3,088,692 -333,729	-10%	-$27.7M	0.26%	87
2014 Q3	$278M	Buy	3,422,421 +138,400	+4%	+$11.1M	0.28%	82
2014 Q2	$265M	Buy	3,284,021 +200,782	+7%	+$16.1M	0.27%	85
2014 Q1	$246M	Buy	3,083,239 +199,855	+7%	+$16.4M	0.26%	89
2013 Q4	$237M	Sell	2,883,384 -24,294	-0.8%	-$1.84M	0.27%	85
2013 Q3	$214M	Buy	2,907,678 +197,381	+7%	+$14.6M	0.26%	96
2013 Q2	$195M	Buy	+2,710,297	New	+$215M	0.25%	105

Other funds holding ACN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM's ACN Position: Q1 2026 in Review

UBS AM increased its Accenture (ACN) stake by 7.9% in Q1 2026, buying an estimated $99.6M and bringing the position to 5,821,349 shares worth $1.15B. The position accounts for 0.24% of the portfolio, ranked #83.

UBS AM first reported a position in ACN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.12B in Q4 2024. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

UBS AM held 5,821,349 shares of Accenture worth $1.15B as of Q1 2026.
UBS AM bought 427,531 Accenture shares in Q1 2026, an estimated $99.6M.
Accenture made up 0.24% of UBS AM's portfolio in Q1 2026, its #83 holding.
UBS AM first reported a position in Accenture in Q2 2013 and has held it in 52 quarters since.
UBS AM's Accenture position peaked at $2.12B in Q4 2024.
2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.